Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02640833
Title A Study of Duvelisib and Venetoclax in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Indolent or Aggressive Non-Hodgkin Lymphoma, Who Have Not Previously Received a Bcl-2 or PI3K Inhibitor
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors AbbVie
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Site Reference ID/Investigator# 145677 Tucson Arizona 85724-5024 United States Details
Site Reference ID/Investigator# 147922 Chicago Illinois 60611 United States Details
Site Reference ID/Investigator# 148562 Harvey Illinois 60426 United States Details
Site Reference ID/Investigator# 148561 Goshen Indiana 46526 United States Details
Site Reference ID/Investigator# 145674 Baltimore Maryland 21287 United States Details
Site Reference ID/Investigator# 145145 Boston Massachusetts 02215 United States Details
Site Reference ID/Investigator# 148010 Detroit Michigan 48202 United States Details
Site Reference ID/Investigator# 147747 St. Louis Missouri 63110 United States Details
Site Reference ID/Investigator# 145146 Lebanon New Hampshire 03756 United States Details
Site Reference ID/Investigator# 148559 Greenville South Carolina 29605 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field